Wyeth, Orchid Reach Deal In Effexor Patent Fight
Under the settlement, Orchid agreed not to manufacture venlafaxine HCl extended-release capsules — the active ingredient in the drug — until the expiration of three relevant patents, except as permitted by a confidential licensing agreement.
Wyeth and Orchid submitted the deal to Judge Freda L. Wolfson of the U.S. District Court for the...
Already a subscriber? Click here to login